Td Waterhouse Canada Inc. Neurocrine Biosciences Inc Transaction History
Td Waterhouse Canada Inc.
- $14.8 Trillion
- Q2 2024
A detailed history of Td Waterhouse Canada Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 41 shares of NBIX stock, worth $4,787. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41
Previous 41
-0.0%
Holding current value
$4,787
Previous $5.64 Million
35.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
631Shares Held
95.4MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.66 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.17 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$538 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$288 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$276 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...